Astec Lifesciences has announced the appointment of Burjis Godrej as Managing Director of the company for a term of five years with effect from 1st April, 2025 upto 31st March, 2030, without any remuneration payable to him in such capacity.

Burjis Godrej is a Non-Executive, Non-Independent Director of the company since 25th July, 2022. He is currently Executive Director of Godrej Agrovet Limited (GAVL), the holding Company. His role involves evaluation of products, synergies, technologies, business models, geographies, consultant engagements, customer and supplier relations and Capex plans.

Burjis Godrej has completed his MBA from Harvard Business School in 2021. He first joined GAVL in 2017 working on new product development in the Strategy team. His role involved monitoring Research & Development (R&D) activities, product quality improvement, new product trials and innovation partnerships with external organizations.

Before joining GAVL, he worked for Conservis Corporation, a firm that provides software for farmers (now a Joint Venture between RaboBank and Tellus Corporation). His role there involved software implementation, customer success, water quality monitoring and sales development.